Condition (MeSH)
Cellulite
ClinicalTrials.gov lists 64 trials for Cellulite or a narrower condition beneath it. Endo USA Inc., a Keenova Therapeutics Company has the most among industry and government lead sponsors, with 18.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
64 of the 64 trials are tagged with Cellulite itself; the rest are tagged with a narrower condition beneath it.
When did Cellulite trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 8
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 3 |
| 2023 | 8 |
| 2022 | 4 |
| 2021 | 6 |
| 2020 | 4 |
| 2019 | 6 |
| 2018 | 7 |
| 2017 | 2 |
| 2016 | 4 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 3.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cellulite trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 11 |
| Phase 3 | 4 |
| Phase 4 | 7 |
| Not applicable | 31 |
| Observational | 6 |
How many Cellulite trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 52 |
| Suspended | 1 |
| Terminated | 5 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Cellulite trials? (9)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Endo USA Inc., a Keenova Therapeutics Company | 18 |
| Soliton | 3 |
| Caliway Biopharmaceuticals Co., Ltd. | 2 |
| Cutera Inc. | 2 |
| Galderma R&D | 2 |
Showing 5 of 9 sponsors.
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Clostridium Histolyticum Collagenase | 9 |
| EN3835 | 4 |
| CCH-aaes | 3 |
| Previously Treated with EN3835 | 2 |
| 80 mg CBL-514 | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Cellulite trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Abortion spontaneous | 2 | 2 |
| Appendicitis | 1 | 1 |
| Arthralgia | 1 | 1 |
| Asthma | 1 | 1 |
| Breast Cancer | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Cellulite? (21)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Comparing safety and efficacy of acoustic subcision at two different rapid acoustic pulse rates to improve the appearance of cellulite. | Lasers in surgery and medicine | 2024 | Yes |
| Safety and Efficacy of Diluted Calcium Hydroxylapatite for the Treatment of Cellulite Dimpling on the Buttocks: Results from an Open-Label, Investigator-Initiated, Single-Center, Prospective Clinical Study. | Aesthetic plastic surgery | 2024 | Yes |
| Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: Final Results at 12 Months. | Aesthetic surgery journal | 2023 | Yes |
| Skin Tightening With Hyperdilute CaHA: Dilution Practices and Practical Guidance for Clinical Practice. | Aesthetic surgery journal | 2022 | Yes |
| Study of a New Controlled Focal Septa Release Cellulite Reduction Method. | Aesthetic surgery journal | 2022 | Yes |
Showing 5 of 21 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.